Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.74 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.48 |
| ▸ | CDC7 | O00311 | 1/20 | 0.47 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6502484 | 0.88 | L3MBTL1 (0.58) | L3MBTL1PTGDR2KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL5238288 | 0.88 | L3MBTL1 (0.58) | L3MBTL1PTGDR2KDM4EALDH1A1CDC7 | |
| SCHEMBL6503373 | 0.86 | L3MBTL1 (0.57) | L3MBTL1PTGDR2KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL6431720 | 0.86 | L3MBTL1 (0.56) | L3MBTL1KDM4EPOLBTRPM8ALDH1A1 | |
| SCHEMBL12875848 | 0.86 | L3MBTL1 (0.56) | L3MBTL1PTGDR2KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL1246771 | 0.85 | L3MBTL1 (0.71) | L3MBTL1PTGDR2KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL27500333 | 0.85 | L3MBTL1 (0.56) | L3MBTL1PTGDR2KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL12049566 | 0.83 | L3MBTL1 (0.60) | L3MBTL1PTGDR2KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL13898599 | 0.83 | L3MBTL1 (0.53) | L3MBTL1PTGDR2KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL5341433 | 0.82 | L3MBTL1 (0.55) | L3MBTL1PTGDR2KDM4EPOLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1102757-B1 | SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS | GLAXO GROUP LTD (GB) | 2004-04-14 | — | — | EP | disclosed |
| US-6498174-B1 | AGONISTS TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; MODULATING BLOOD GLUCOSE AND LIPID LEVELS; REDUCING DYSLIPIDEMIA AND HYPERINSULINEMIA ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE OR METABOLIC SYNDROME | SMITHKLINE BEECHAM CORPORATION | 2002-12-24 | — | — | US | disclosed |
| EP-1102757-A1 | SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS | GLAXO GROUP LIMITED (GB) | 2001-05-30 | — | — | EP | disclosed |
| WO-2000008002-A1 | SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS | GLAXO GROUP LIMITED (GB) | 2000-02-17 | — | — | WO | disclosed |